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Norman Bethune College of Medicine, Jilin University, Changchun, P. R. China
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Cadmium (Cd) is an important nephrotoxic pollutant. To examine late effects on the
kidney of individuals previously exposed to chronic Cd at very low levels, male Wistar rats
were given 20 nmol/kg i.p. injections of Cd every other day for 4 weeks. At the 20th, 28th,
36th, 44th and 52nd week of the study, renal metal accumulation, morphology and function
were examined. Immunochemical staining was performed to detect renal 3-nitrotyrosine
(3-NT) accumulation, metallothionein (MT) expression, cell proliferation and global DNA
methylation. Results showed that renal Cd concentration and MT expression along with 3NT accumulation were significantly higher in the Cd group than that in the control.
Histopathologically renal tubule damage at the early stage and hyperplasia at the late stage
were observed in the Cd group. Renal fibrosis in glomeruli was evident in the Cd group,
particularly at the late stage of the study. Immunoreactivity of global DNA methylation was
markedly diminished in the Cd group at both 20th and 52nd weeks. These results suggest
that previous exposure to chronic Cd at very low level induced persistent damaging effects
on the kidney along with increases in cell proliferation and global DNA hypomethylation.
䊐

Key Words: Cadmium; renal toxicity; persistent effect; renal dysfunction; methylation

INTRODUCTION

Cadmium (Cd) is a nonessential metal that causes several human diseases and has been classified as a human carcinogen by the National
Toxicology Program of the USA (ATSDR, 2004). Several population stud-
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ies have shown that not only occupationally Cd-exposed workers but also
environmentally Cd-exposed populations can experience moderate to
severe health problems (Bernard et al. 1992; Bernard et al. 1990; Jarup
and Alfven 2004). Unfortunately, human contact with Cd is an
inescapable consequence of human life, from both occupational and
environmental sources. The environmental exposure of Cd occurs mainly from consumption of contaminated food, active and passive inhalation
of tobacco smoke, and inhalation by workers in the non-ferrous metal
industry. In humans and other mammals, Cd adversely affects a number
of organs and tissues, with the kidney and liver as two primary target
organs (Zalups and Ahmad 2003). Chronic exposure to low-level Cd has
been associated with a number of pathogenic changes, such as the endstage renal failure, early onset of diabetic renal complications, and
increased cancer risk (Jarup 2002; Nakagawa and Nishijo 1996). Cd accumulates primarily in the kidney and is eliminated very slowly with a halflife of 15–20 years (Jarup 2002). In our recent study, we observed a persistent increase of hepatic cell proliferation in the rats at 44th and 52nd
weeks after chronic exposure to Cd at low dose (Wang et al. 2011).
The biological effects of Cd at high doses have been extensively investigated (Moulis and Thevenod 2010). Chronic exposure of animals to Cd
at low levels has been studied by several groups (Bernard et al. 1992;
Bernard et al. 1990; Jarup and Alfven 2004). However, most of those studies have focused on the effects during or at the end of Cd exposure.
Recently whether the toys and jewelries containing small amount of
Cd that contributes to a resource for children’s Cd contamination should
be banned in order to avoid the potential toxicity of Cd are debated
(Mead 2010). The debate is mainly because we do not know whether exposure of the individuals to Cd at very low levels, although it does not produce significant acute toxicity, can induce a late or long-lasting effect
(Mead 2010). However, there was an indirect evidence that previous smokers had increased risk of renal dysfunction compared to non-smokers
(Cooper 2006). Since tobacco smoking increases systemic Cd levels, previous Cd exposure due to smoking may cause a long-lasting toxic effect.
In this study, therefore, we aimed at investigating renal response at
functional, histopathological and biochemical levels in rats previously
exposed to chronic Cd at very low dose (20 nmol/kg body weight). CPSC
2010’s has published an acceptable daily intake level of 0.1 µg/kg body
weight/day for chronic exposure (Mead 2010). We decided to examine
whether there was a late or long-lasting renal effect of Cd at about 20
folds of this acceptable daily intake dose (20 nmol/kg/day ≈ 2.25
µg/kg/day), which would be the lowest level of Cd used for animal study
based on our knowledge. In order to address renal effects of Cd at very
low level, we decided to use i.p. injection, instead of dietary administration, of Cd to ensure the accurate dose administration without influence
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of intestinal absorption difference between early and late stages for Cd
ingestion. We examined renal structure and function for the Cd-treated
and age-matched rats at the 20th, 28th, 36th, 44th and 52nd weeks from the
beginning of the 4-week Cd-treatment.
MATERIALS AND METHODS
Animals and Treatment

Thirty-six adult male Wistar rats (6-week old), weighing 180–200g,
were purchased from the Experimental Animal Center of School of Basic
Medical Sciences, Jilin University (Changchun, China). Rats were fed with
standard laboratory chow and tap water ad libitum for 1 week before the
experiments was commenced. The experiments were approved by and carried out in accordance with the regulation of University Animal
Experimentation Committee. These rats were housed in plastic cages with
light and dark (12 h: 12 h) and an ambient temperature of 24°C ± 2°C.
The rats were divided randomly into two groups (n=8), and 2 cages (4
rats/cage) were used separately for each group; (1) control group: rats
were given i.p. injections of saline every other day for 4 weeks. (2) Cd treatment group: rats were given i.p. injections of Cd in saline at 20 nmol/kg
every other day for 4 weeks. Cadmium chloride (CdCl2; purity 99.99 %)
was obtained from Sigma-Aldrich (St. Louis, MO, USA). The time at the
beginning of 4-week Cd exposure was set up as time 0 of the study
(Fig. 1A). From these mice, livers have already been collected and analyzed and published elsewhere (Wang et al. 2011). Since renal toxic effects
of Cd at low doses have been extensively investigated at the end of Cd
treatment (Jarup and Alfven 2004; Jarup et al. 2000; Uriu et al. 2000), our

FIGURE 1. Outline of the study and relative kidney weight. (A) Outline of the animal treatment time
and the time (weeks) of sacrifice. Rats were given i.p. injections of Cd in saline at 20 nmol/kg body
weight every other day for 4 weeks (grey diagonal area). Age-matched control rats were given i.p.
injections with same volume saline every other day for 4 weeks. The beginning of Cd injection was
set as 0, and at the 20th, 28th, 36th, 44th and 52nd weeks of the study, rats were sacrificed. (B) Relative
kidney weight, i.e.: the ratio of kidney weight to body weight, in each rat was analyzed since the body
weight was no different between Cd group and control group (data not shown). Data was presented
as mean ± SD (n=6). *P < 0.05 vs corresponding controls.
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focus here was to investigate whether there remains late or persistent
effects of previous exposure to chronic Cd. Accordingly the experiments
were carried out at the 20th, 28th, 36th, 44th, and 52nd weeks from the beginning of the 4-week Cd exposure, as illustrated in Fig. 1A. Since Wistar rats
have a lifespan of 30 months (LaSarge and Nicolle 2009), these rats at the
time of sacrifice were correspondingly 21.66% (6 weeks old + 20 weeks for
the study) and 48.33% (6 weeks + 52 weeks) of their lifespan, respectively
for the first and last time-points. The rats were weighed and killed using
an overdosage of pentobarbital sodium at 50 mg/kg body weight i.p.
(Sigma, Chicago, USA) at the time of sacrifice. Then the kidneys were
removed quickly from animals, cleaned and washed in precooled saline
several times, and then were portioned and stored at –80°C.
Sample Preparation for Determining Tissue Metal Concentrations

At the time of sacrifice, 100 mg of the kidney in wet weight were
ground, put in scaled glass tube, and then dried in oven at 105 °C for 4 h.
Tissues in the scaled tubes were digested with 0.5 ml 50% (vol/vol) HNO3.
Upon completion of digestion, the inorganic residues were dissolved in
deionizing distillated water until 2 ml and the Cd concentration was measured using inductively coupled plasma mass spectrometry (ICP-MS; Agilent
Technologies, Santa Clara, CA, USA). In addition to Cd, copper (Cu), zinc
(Zn) and calcium (Ca) were measured. Concentrations are reported as
nan- or micro- grams of metal per gram of dry weight (ng or µg/g).
Biochemical Parameters

The concentrations of blood urea nitrogen (BUN) and creatinine
(Cre) in the serum were tested with ROCHE COBAS 400 full-automatic
biochemistry analyzer. Kidney tissue from each rat was homogenized in
10 volumes of precooled phosphate buffered saline (pH 7.4), and the
homogenate was centrifuged at 3,000 × g for 15 min to collect the supernatant for biochemical assays. Activities of superoxide dismutase (SOD)
and contents of glutathione (GSH) and malondialdehyde (MDA) in the
kidney were detected using corresponding commercial assay kits
(Jiancheng, Nanjing, China).
Tissues for Histopathology

For pathological examination for Cd-induced kidney lesions, the tissue was fixed in 10% buffered formalin, embedded in paraffin, and sectioned at 4 µm. After deparaffinization, tissue sections were rehydrated
and stained by hematoxylin and eosin (H&E) and periodic acid-Schiff
(PAS) reagent. Pathological changes of glomeruli, renal tubules and
interstitium were examined by light microscopy. All morphometric and
semi-quantitative analysis were performed in a blinded manner by two
63
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investigators without knowledge of the origin of the section.
Histopathology for tissues was evaluated for at least 10 randomly selected
non-overlapping fields of each section. Mesangial index was assessed
based on at least 20 glomeruli per kidney using computer image analysis
by measuring the proportion of glomerular tuft comprised of extracellular matrix (ECM). The ratio of measured PAS-positive area (ECM) in the
full glomerular area (GA) (i.e., ECM/GA) was used to indicate the magnitude of ECM accumulation as previously described (Song et al. 2004).
Immunohistochemistry

Serial sections at 4 µm in thickness were processed for immunohistochemical staining of proliferating cell nuclear antigen (PCNA), metallothionein (MT), and 3-nitrotyrosine (3-NT). Briefly, the sections were
de-waxed in xylene and rehydrated through descending concentrations
of ethanol and the endogenous peroxidases were blocked with 3 %
H2O2/methanol for 15 min at 37°C. Sections were placed in a moist
chamber and pre-incubated with a protein blocker solution containing
0.1 % BSA and 2 % non-immune goat serum to minimize non-specific
staining. Sections were incubated for 1 h at 37 °C with the primary antibody diluted in an antibody diluting buffer (anti-PCNA antibody at 1/500
dilution, from DAKO, Carpinteria, CA, USA; anti-MT at 1/200 dilution
and anti-3-NT at 1/200 dilution, both from Santa Cruz Biotechnology,
Inc. CA, USA), and then with the biotinylated antibody (goat anti-rabbit
IgG at 1: 300 dilution from DAKO, CA,USA) and the streptavidin-biotinperoxidase complex (1:300 from DAKO) according to the manufacturer’s recommendation. Peroxidases were observed with 3-3’-diaminobenzidine tetrahydrochloride (DAB) (Sigma, Chicago, USA) at room temperature as the chromogen and the sections were briefly counterstained
with hematoxylin. Negative controls were prepared by using 0.1 %
PBS/BSA and non-immune rabbit serum instead of the primary antibody.
Slides were interpreted for antigen expression by two investigators
without knowledge of the pathological information. Sections were considered as MT or 3-NT positive arbitrarily when more than 10% of cell
nuclei and/or cytoplasm were stained for MT or 3-NT. MT or 3-NT negative sections showed no staining for MT or 3-NT. The intensity of MT or
3-NT expression was graded subjectively by two independent observers,
and given a grade from 0 to 4, with a grade of 1 indicating no staining,
and a grade of 4 indicating the greatest intensity of staining. A weighted
score (HSCORE) was then generated to semi-quantify both MT and 3-NT
expression levels in the tissue by multiplying MT or 3-NT intensity score
with the proportion of positively stained renal tissues, based on a published method (McCarty et al., 1985). The proliferation index (PI) was
calculated as the number of PCNA positive cells in 100 cells in a field at
× 200 magnifications.
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Sections at 4 µm in thickness were placed in 0.01 mol/L citric acid
(pH 6.0) in a microwave oven at full potency for 10 min. After the antigen retrieval, slides were immersed in 3.5N HCL for 15 min at room temperature to expose CpGs. The rest part of this staining is same as
described above for other immunohistochemical staining. Sections were
incubated with anti-5-methyl cytidine mouse monoclonal antibody
(1/100; Abcam, Cambridge, MA, USA).
Statistical Analysis

Data are expressed as the mean ± SD. One-way ANOVA was used to
determine if differences exist and if so, a post hoc Tukey’s test was used
for analysis of the difference between groups with Origin 7.5 laboratory
data analysis and graphing software. Statistical significance was considered as p < 0.05.
RESULTS
Animal Model and Renal Metals

Previous exposure of rats to chronic Cd at very low level did not alter
the body weight gain and animal survival rate (Data not shown). Relative
weights of the kidney to body weight in Cd-treated rats were lower than
that in control group only at the 20th week (Fig. 1B).
In control rats, renal Cd levels showed a slight increase in an agedependent manner (Fig. 2A), while renal Zn, Cu and Ca did not significantly change as age increases (Fig. 2B,C, D). In Cd groups, renal Cd
accumulation was significantly high at the 20th week and gradually
decreased until the 52nd week where it remained high compared to control (Fig. 2A). In contrast to Cd concentration, renal Zn level was low in
the Cd group at the 20th week (P < 0.05) and gradually returned to normal level at the 52nd week (Fig. 2B). Renal Cu was not significantly high
in Cd groups from the 20th to 36th weeks, but significantly high in Cd
groups from the 44th to the 52nd weeks, compared to controls (Fig. 2C).
Renal Ca was slightly low in Cd groups from the 20th to 28th weeks and
then gradually increased from the 44th week until 52nd week where it was
significantly higher than that of the control (Fig. 2D).
Changes of Renal Function and Structure

There was no significant difference between controls and Cd groups
for serum BUN and Cre levels at the most of time-points except for the
time-point of 36th week where both serum BUN (P < 0.05) and Cre (P <
0.01) levels were transiently increased in the Cd group compared to the
control (Fig. 3A, B).
65
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FIGURE 2. Renal metal contents. Renal tissues were weighted, dried and then measured with ICP-MS
assay for Cd (A), Zn (B), Cu (C) and Ca (D) levels. Concentrations of these metals are expressed as ng
or µg/g dry weight tissues. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls.

FIGURE 3. Changes of renal function and structure. Renal function was evaluated by BUN (A) and
serum Cre (B) concentrations. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls. Histological changes of the kidney (C) were examined under light microscope with H&E staining
at the indicated times. Arrows indicate the hyperplasia in the proximal tubule cells. Bar = 100 µm.

Histopathological analysis with H&E staining showed that renal
tubules in controls were regularly arranged without damage. Renal
epithelia in controls were dense, located in the basement of the lumen
66
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and microvillus brush borders. In Cd groups, however, abnormal structure of renal tubules were present at the 20th week, with sparse lumens
that varied in size and sparse epithelia that were physalides and dropsical
and even moved upward to the lumen. Microvillus brush borders were
wavy and some have shed, resulting in a shape of mesh. As the time
increased, the above pathological changes in Cd groups were recovered
gradually, but at the 44th week, hyperplasia, nuclear enlargement and
chromatin thickening of individual cells in some renal tubules (see
arrows) became evident and at the 52nd week, the hyperplasia cells were
congregated at single tubule (Fig. 3C).
Renal fibrosis was examined with PAS staining (Fig. 4), which showed
gradual increases in PAS density in renal tissues and a significant renal
fibrosis, characterized by mesangial expansion and extracellular matrix
accumulation of PAS-positive materials in Cd groups (Fig. 4A). Semiquantitative analysis of mesangial index was performed based on PAS
staining (Fig. 4B), using the criteria described in Materials and Methods.
Previous exposure of rats to chronic Cd at very low level induced a significant increase in mesangial index.
Oxidative Damage and Antioxidant Levels in the Kidney

To examine the status of renal oxidative stress and damage, renal total
glutathione (GSH) levels and superoxide dismutase (SOD) activities as
antioxidant status were examined (Table 1). There was no significant
change for GSH level at any time-point of the study. Renal SOD activity significantly decreased from the 36th week until the 52nd week of the study.
Renal oxidative damage was evaluated by renal tissue urea, lipid peroxidation (MDA) and protein nitration (3-NT). There was no significant
difference between control and Cd groups for renal urea and MDA levels
(Table 1). Immunochemical staining for 3-NT showed no positive staining in control groups (Fig. 5A), but a significant increase in staining
intensity in Cd groups, which was strongest at the 20th week and then
gradually weaken until the 52nd week where it remained high compared
to control (Fig. 5A, B).
MT as both metal binding protein and antioxidant was also detected
by immunochemical staining (Fig. 6). MT expressed in both glomeruli
and tubules, mainly in the cell plasma (Fig. 6A). Semi-quantitative analysis of MT expression with the immunochemical score (HSCORE) system,
as described in Materials and Methods, showed that MT levels in outer
medulla were significantly higher in Cd groups with the highest level at
the 20th week, and then gradually decreased until the 52nd week where it
remained higher than that of control (Fig. 6B, C). The expression of MTs
in proximal tubules of the inner medulla (staining images were not
shown; semi-quantitative analysis shown in Fig. 6D) was similar to that of
the outer medulla (Fig. 6C).
67
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FIGURE 3. Continued

Renal Cell Proliferation

To evaluate whether chronic renal damage induced by Cd at very low
level is accompanied with cell proliferation change, renal tissue was
stained for PCNA. PCNA positive staining cells were observed in the kid68
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FIGURE 4. PAS staining for renal fibrosis. Renal sections from Cd-treated and control rats were stained
for PAS, which showed increases PAS-positive materials in glomeruli. Bar = 100 µm. Renal histological
changes were semi-quantitatively evaluated under light microscopy based on PAS staining for the
mesangial damage index. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls.
TABLE 1. Data on Oxidative damage and antioxidant levels in the kidney tests at the indicated
times.
Parameters

Group

20W

28W

36W

44W

52W

MDA (nmol/mg prt.)

Control
Cd
Control
Cd
Control
Cd
Control
Cd

2.51±0.60
2.44±0.66
49.02±2.43
49.91±3.14
15.05±0.86
14.76±1.04
15.79±2.35
16.19±2.72

2.66±0.76
2.63±0.76
52.21±2.58
52.47±3.32
15.78±0.84
15.89±0.88
17.65±2.96
17.02±1.99

2.59±0.71
2.64±0.73
51.05±3.80
39.23±2.13*
15.19±0.45
15.64±1.38
18.09±2.71
17.91±1.58

2.46±0.63
2.53±0.41
53.92±3.17
43.85±1.86*
15.95±1.07
15.28±0.95
19.24±2.62
19.68±1.09

2.64±0.61
2.57±0.58
53.12±1.51
43.72±1.99*
15.32±1.28
15.28±0.67
18.87±2.38
19.02±2.89

SOD (U/mg prt.)
GSH (gGSH/g prt.)
Urea (mg/dL)

Data were expressed as mean ± SD (n = 6); prt.: protein; *P < 0.05 vs control.
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FIGURE 5. Immunohistochemical staining for 3-NT. (A) Representative microscopic images of the
3-NT, showing an increase in 3-NT accumulation in the kidney of Cd group compared to control. Bar
= 100 µm. (B) Semi-quantitative analysis for the 3-NT accumulation in the renal cortex was performed with SCORE. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls.
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FIGURE 6. Renal MT expression by immunohistochemical method for MT. Renal sections were
immunohistochemically stained for MT. A: Representative images of positive MT staining in three
typical regions of the kidney. B: Representative images of MT staining in outer medullar from control and Cd groups. Bar = 100 µm. C, D: Semi-quantitative analysis for MT expression in the outer
medullar and the inner medullar (staining images were not shown here), respectively, was performed
with HSCORE. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls.
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FIGURE 6. Continued

ney of Cd groups and were further evaluated separately by glomerular
(Fig. 7A) and tubular (Fig. 7 B) parts. Mesangial cell proliferation was significantly lower at the 20th and 28th weeks and significantly higher at 52nd
week in Cd groups than those in controls (Fig. 7A). Cell proliferation in
the renal tubules was significantly lower at the 20th and 28th weeks, but significantly higher at the 44th and 52nd weeks in Cd groups than those in the
controls (Fig. 7B). The finding of proliferative renal tubular epithelia
cells (Fig. 7B) is consistent with the tubular hyperplasia at late time-points
of the 44th and 52nd weeks shown in Fig. 3C.
Global DNA Methylation Status in the Kidney

Next the change of global DNA methylation status were examined for
kidney tissues from controls and Cd groups by immunohistochemical
staining with monoclonal antibody against 5-methyl-cytidine (Fig. 8).
Cells with positive staining of DNA methylation were observed among
glomerular and tubular epithelial cells in normal kidneys. In Cd groups,
however, immunoreactivity of 5-methyl-cytidine in the kidney was
markedly decreased at both early (the 20th week) and late (the 52nd week)
time-points, compared to the controls.
DISCUSSION

The present study demonstrates, for the first time, the long-lasting
effect of Cd on the kidney of the rats previously exposed to chronic Cd at
very low level. We showed that previous exposure of rats to Cd at very low
level did not affect body weight, but reduced the ratio of kidney/body
weights at the early stage (likely before the 20th week). Renal Cd accumulation lasted for a long time even until 52 weeks (remaining about 5
times higher than that of control), although it gradually decreased from
the 20th to the 52nd week. Renal Cd accumulation was correlated with
slight decreases in renal Zn and Ca levels at the early stage (the 20th
week), but not at late stages. Renal Cd accumulation was associated with
72
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FIGURE 7. Immunohistochemical staining for proliferating cells. PCNA as an index of cell proliferation was examined by immunohistochemical stain in the glomeruli (A) and the renal tubular (B),
followed by semi-quantitative analysis for the proliferation index (PI). Bar = 100 µm. Data was presented as mean ± SD (n=6). *P < 0.05 vs corresponding controls.

renal nitrosative damage, measured by 3-NT accumulation, and increased
MT expression. All these three measurements showed a time-dependent
decrease from the 20th to the 52nd weeks of the study. Previous exposure
to Cd at such low levels also induced the persistent renal fibrosis and cell
proliferation. Immunohistochemical staining of 5-methyl-cytidine
showed a persistent decrease in global DNA methylation.

73
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FIGURE 7. Continued

Renal accumulation of Cd in animals or humans exposed to chronic
Cd has been extensively reported (Bernard 2004; Callegaro et al. 2010;
Koizumi et al. 2008; Takaki et al. 2004; Zager 2005). Groten et al. (1991)
have demonstrated that rats were fed with diets containing Cd as CdCl2
either at 30 mg/kg that contributed a daily intake of Cd from 1-2.5
mg/kg body weight or at 1- 8 mg/kg that contributed a daily intake of Cd
from 0.13 to 0.26 mg/kg body weight for 4 weeks. Both treatments resulted in a time-dependent increase in liver and renal Cd accumulation during the exposure period. Cd was predominantly distributed to the liver
when rats were exposed to Cd at high doses while it was predominantly
74
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FIGURE 8. Immunohistochemical staining for global DNA methylation. Global DNA methylation status was examined with immunohistochemical staining for controls and Cd-treated kidneys, as
described in Materials and Methods. Bar = 100 µm.

distributed to the kidney when rats were exposed to Cd at low doses. Up
to date, however, whether previous exposure of animals or human to Cd
at very low levels causes a long-lasting renal Cd accumulation remained
unaddressed yet. Therefore, the first novelty of this study is to show that
previous exposure of the rats to Cd at very low level resulted in a long-lasting renal Cd accumulation that, although gradually decreased, remained
significantly higher than control levels even at the 52nd week (Fig. 2A).
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The long-lasting accumulation of renal Cd is mainly due to the slow elimination of Cd as reported previously: approximately 0.001% of Cd in the
body is excreted per day mostly via urine, and may be also due to redistribution from other organ’s Cd such as the liver (Satarug and Moore
2004). The slow elimination of renal Cd accumulation is also reflected in
control rats. From Fig. 1A, we found that there was a slight, but steady
age- or time-dependent increase in renal Cd accumulation in the control
group. The main reason may be the age-dependent accumulation of Cd
intake from control diet that included very low levels of Cd from 0.1 mg
Cd/kg non-dry weight (Asagba and Obi, 2005) or 1 mg/kg dry weight
diet (Haouem et al. 2007). Haouem et al. (2007) have reported that when
Wistar rats were fed with normal diet for 4 (16 weeks) to 12 months (48
weeks), they found the liver Cd accumulation from 20 to 40 ng/kg which
is close to our finding for the renal Cd accumulation from 35 ng/kg at
the 20th week to 50 ng/kg at the 52nd week of the study (Fig. 1A).
Studies have repeatedly indicated that Cd toxicity and carcinogenicity involve multiple steps: inducing reactive oxygen and/or nitrogen
species (ROS and/or RNS) generation, depressing antioxidant function,
and inhibiting the enzymes responsible for DNA repair (Hradilova et al.
2010; Schwerdtle et al. 2010; Waalkes 2000). Tissues exposed to acute or
chronic Cd at relative high doses often showed the oxidative damage,
mirrored by increased renal MDA contents and decreased SOD activity
during or at the end of Cd treatment (Amara et al. 2006; Renugadevi and
Prabu 2010; Xu et al. 2010). However, no study has attempted to define
whether these oxidative endpoints persistently exist if examined at very
late stage after Cd treatment. In the present study, we did not observe significant increases in oxidative damage, measured by renal tissue urea and
MDA levels at the 20th to 52nd weeks of the study (Table 1). Since we did
not measure the MDA contents during Cd treatment, it is unclear
whether renal lipid peroxidation increased during Cd-treatment, which
may become a limitation for the present study.
Regarding the fact that although there was a long-lasting renal Cd
accumulation, there was lack of a long-lasting oxidative renal damage, we
need to consider the following reasons: (1) Age may be one of the susceptible determinates to Cd-induced renal lipid peroxidation. Shibasaki
et al. (1996) have reported that when they treated both young and old
hamsters with Cd, they found that renal MDA content was significantly
increased only in young animals exposed to Cd. In the present study, the
rats are relative old: i.g. about 26 weeks old at the earliest time-point (6
week old before starting study + 20 weeks of the study) and 58 weeks old
at the latest time-point (6 weeks + 52 weeks); (2) It was reported that
renal MDA was found to be increased in response to acute Cd exposure,
and did not increase or even decrease in response to chronic Cd exposure (El-Maraghy et al. 2001); (3) MDA measurement may not sensitive
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enough to detect the mild increase in MDA level in whole kidney; therefore, immunohistochemical staining of 3-NT was also used as an index of
protein nitration (a nitrosative damage) in the present study. We showed
a significant increase in 3-NT accumulation predominantly distributed in
renal tubules at the 20th week and gradual decrease until the 52nd week
(Fig. 5). Several key antioxidants in tissue cells, most notably SOD and
catalase, were reported to be decreased in response to Cd treatment
(Uchida et al. 2004; Waisberg et al. 2003). We also found that the total
SOD activity decreased, starting from the 36th week (Table 1). This suggests that Cd may not produce significant free radical species by itself, but
rather impair the normal free-radical scavenging system (Stohs et al.
2001). Regarding to the mechanism responsible for the effect of Cd in
decreasing renal SOD activity, we know that most of the antioxidant
enzymes become inactive by Cd exposure due to the direct binding of Cd
to enzyme active sites if they contains SH groups (Quig 1998) or displacement of metal cofactors from active sites (Casalino et al. 2000). For
instance, Bauer et al. (1980) have reported that Cd111 was able to occupy
the site of Zn in the CuZn–SOD molecule creating an inactive form of the
enzyme (CuCd111SOD).
MT is a cysteine-rich low molecular weight protein, which can bind
excess heavy metal ions preventing their toxic effects, and also sequesters
several ROSs and RNSs to play an important role in protecting against
oxidative stress (Cai et al. 1999; Cai et al. 2000; Cherian et al. 2003; Sato
and Bremner 1993). Cd is readily able to induce MT expression in the
liver and kidney (Cherian et al. 2003). We found that MT expression was
up-regulated in both tubules and glomeruli of the kidney at the 20th week
and then was gradually decreased in a time-dependent manner until the
52nd week, but remained higher than control level (Fig. 6). Up-regulated
renal MT expression may be induced by the accumulated Cd in the kidney so that MT may be a protective mechanisms at the early stage to prevent the kidney (Sato and Kondoh 2002).
In addition, MT up-regulation in the kidney may be responsible for
the long-lasting Cd accumulation. MT binds Cd with a high affinity,
resulting in a decreased availability of free Cd2+ capable of interacting
with cellular targets to avoid the acute toxicity of Cd. These assumptions
are supported by the fact that mice with lack of MT genes are highly susceptible to Cd-induced renal toxicity (Liu et al. 1998; Liu et al. 2000).
However, although renal MT binds Cd that avoids acute renal damage,
MT that bound Cd in the kidney may remain slowly releasing Cd that continually induces mild renal damage. Our results showed persistent pathological lesions in the kidney, including tubular degeneration, glomerular
cell proliferation and swelling, and interstitial fibrosis. Other studies also
showed that exposure to Cd at low levels can cause renal damage (Jarup
et al. 2000).
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In the present study, we used immunohistochemical detection of
PCNA. We found a significant increase in renal glomerular and tubular
cell proliferation at the late stage (Fig. 7). PCNA is a marker for cells in
early G1 and S phases of the cell cycle. Chronic exposure to Cd can damage renal proximal tubular epithelial cells of S1 and S2 segments
(Conner and Fowler 1993). Our results indicate that the previous exposure of rats to chronic Cd at very low level interfered with the normal synthesis of DNA, including the inhibitive effect on cell proliferation at early
stage and stimulating effect on DNA synthesis and cell proliferation at the
late stage (Fig. 7). In our recent study, we observed a persistent increase
of hepatic cell proliferation in the rats at 44th and 52nd weeks after chronic exposure to Cd at low dose (Wang et al. 2011).
Many studies over the years have yielded evidence that Cd may contribute to renal cancers in humans (Waalkes 2003). Our study showed
that the structure of renal tubules was impaired at the early phase and
proliferative cells were observed in the later phase, which could be a
pathological basis of renal carcinogenesis. Currently Cd is predominantly considered as a non-genotoxic carcinogen (Jiang et al. 2008). However,
Cd is known to bind to specific sites in chromatin, and such binding
might possibly interfere with the transcription of certain genes.
Epigenetics can be described as a stable alteration in gene expression
without any change in gene sequence (Klein 2005). Reportedly Cd is an
effective inhibitor of DNMTs and induces DNA hypomethylation in vitro
(Takahashi et al. 2003). Consistent with this notion, we demonstrated that
global DNA methylation was markedly diminished in the glomeruli and
tubules of kidneys from Cd-treated rats at both early (the 20th week) and
late (the 52nd week) stages (Fig 8). These results imply that previous Cd
exposure even at very low level may disrupt DNA methylation, as previously observed in vitro studies (Jiang et al. 2008; Singh et al. 2009), which
may explain the long-lasting effect of Cd on renal cell proliferation and
may also be one of the possible underlying carcinogenic mechanisms of
Cd. However, we do not have any further evidence now to determine
whether there will be a real risk for the development of renal cancers in
these Cd-treated rats under the present experimental conditions, and if
so, whether it will be really related to the aberrant methylation.
In summary, we have studied renal functional, structural and biochemical changes in the rats previously exposed to chronic Cd at very low
level. We demonstrated the persistent damaging effect on the kidney of
these rats. The renal accumulation of Cd can last at high level for 52
weeks, which was accompanied with mild oxidative damage, and persistent cell proliferation and DNA hypomethylation. Whether these pathogenic alterations are causative of the development of renal dysfunction or
possible cancer remains further exploration. In addition, whether there
will be gender-dependent effects remains unclear since we did not
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include female in the present study, which will be also warranted in the
future studies.
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